World’s first dengue vaccine ‘Dengvaxia’ has received approval in 14 countries.
Recent approvals were granted in Indonesia, Thailand and Singapore.
Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore have already granted it the approval.
Sanofi-Pasteur — a unit of French pharmaceutical company Sanofi manufactures this vaccine for dengue.
In the clinical study population nine years old and older, the dengue vaccine has been documented to prevent two-thirds of dengue cases due to all four serotypes of dengue.